(VIANEWS) – CTT CORREIOS PORT (CTT.LS), NAVAMEDIC (NAVA.OL), ASM INTERNATIONAL (ASM.AS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. CTT CORREIOS PORT (CTT.LS)
327.5% sales growth and 22.58% return on equity
CTT – Correios De Portugal, S.A., together with its subsidiaries, provides postal and financial services worldwide. It operates through Mail, Express & Parcels, Financial Services & Retail, and Bank segments. The company offers courier and urgent mail transport services; postal financial services; and banking services. It also engages in the business of payments related to collection of invoices and fines. In addition, the company enables the payment of various services and utilities through a network of approximately 5,000 agents covering business outlets as stationery stores, tobacco shops, kiosks, and supermarkets. It operates a retail network of 566 post offices; 1,808 postal agencies; 223 postal delivery offices; 4,576 postal delivery routes; and a fleet of 3,925 vehicles. The company was formerly known as Correio Publico. CTT – Correios De Portugal, S.A. was founded in 1520 and is headquartered in Lisbon, Portugal.
Earnings Per Share
As for profitability, CTT CORREIOS PORT has a trailing twelve months EPS of €0.11.
PE Ratio
CTT CORREIOS PORT has a trailing twelve months price to earnings ratio of 33.91. Meaning, the purchaser of the share is investing €33.91 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.58%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 18, 2022, the estimated forward annual dividend rate is 0.12 and the estimated forward annual dividend yield is 3.41%.
Volume
Today’s last reported volume for CTT CORREIOS PORT is 11462 which is 97.22% below its average volume of 413679.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.1%, now sitting on 893.88M for the twelve trailing months.
2. NAVAMEDIC (NAVA.OL)
74.6% sales growth and 16.31% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, women's health, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr0.47.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 81.49. Meaning, the purchaser of the share is investing kr81.49 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.31%.
Volume
Today’s last reported volume for NAVAMEDIC is 21063 which is 8.3% below its average volume of 22970.
Revenue Growth
Year-on-year quarterly revenue growth grew by 28.6%, now sitting on 382.14M for the twelve trailing months.
3. ASM INTERNATIONAL (ASM.AS)
22.2% sales growth and 12.52% return on equity
ASM International NV, together with its subsidiaries, engages in the research, development, manufacture, marketing, and servicing of equipment and materials that are used to produce semiconductor devices in the United States, Europe, and Asia. Its products include wafer processing deposition systems for single-wafer atomic layer deposition, plasma enhanced chemical vapor deposition, epitaxy, and batch diffusion/furnace systems, as well as provides spare parts and support services. The company also manufactures and sells equipment, which is used in wafer processing, encompassing the fabrication steps in which silicon wafers are layered with semiconductor devices. It serves manufacturers of semiconductor devices and integrated circuits. The company was formerly known as Advanced Semiconductor Materials International NV. ASM International NV was incorporated in 1968 and is headquartered in Almere, the Netherlands.
Earnings Per Share
As for profitability, ASM INTERNATIONAL has a trailing twelve months EPS of €5.89.
PE Ratio
ASM INTERNATIONAL has a trailing twelve months price to earnings ratio of 53.29. Meaning, the purchaser of the share is investing €53.29 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.52%.
Moving Average
ASM INTERNATIONAL’s worth is higher than its 50-day moving average of €290.68 and way above its 200-day moving average of €268.23.
4. AIRBUS (AIR.PA)
10.8% sales growth and 53.48% return on equity
Airbus SE engages in the designing, manufacturing, and delivering aerospace products, services, and solutions worldwide. It operates through three segments: Airbus, Airbus Helicopters, and Airbus Defence and Space. The Airbus segment develops, manufactures, markets, and sells commercial jet aircraft of approximately 100 seats; and regional turboprop aircraft and aircraft components, as well as provides aircraft conversion and related services. The Airbus Helicopters segment engages in the development, manufacturing, marketing, and sale of civil and military helicopters; and provision of helicopter related services. The Airbus Defence and Space segment designs, develops, delivers, and supports military aircraft, such as combat, mission, transport, tanker aircraft, and their associated services; and offers unmanned aerial systems. This segment also offers civil and defense space systems for telecommunications, earth observations, navigation, science, and orbital systems; missile systems; and space launcher systems, as well as services around data processing from platforms, secure communication, and cyber security. The company was formerly known as Airbus Group SE and changed its name to Airbus SE in April 2017. Airbus SE was incorporated in 1998 and is based in Leiden, the Netherlands.
Earnings Per Share
As for profitability, AIRBUS has a trailing twelve months EPS of €-0.38.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 53.48%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Apr 19, 2022, the estimated forward annual dividend rate is 1.5 and the estimated forward annual dividend yield is 1.34%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 203.4% and 0.7%, respectively.
5. MPC CONTAINER SHIP (MPCC.OL)
8.3% sales growth and 70.89% return on equity
MPC Container Ships ASA owns and operates a portfolio of container vessels. The company focuses on feeder vessels between 1,000 and 5,000 twenty-foot equivalent units (TEU). It operates a fleet of 75 ships with a total capacity of 158,000 TEU. The company charters out its vessels to liner shipping companies and regional carriers. MPC Container Ships ASA was incorporated in 2017 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, MPC CONTAINER SHIP has a trailing twelve months EPS of kr10.96.
PE Ratio
MPC CONTAINER SHIP has a trailing twelve months price to earnings ratio of 1.73. Meaning, the purchaser of the share is investing kr1.73 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 70.89%.
